Rockville, MD -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin®“

read more>>

Physicians and scientists agree: If we cannot entirely prevent cancer, the next best thing is to find it earlier to augment the chances of a successful fightThe good news is that there may soon be a new weapon in the battle against the so-called "worst" cancer — cancer of the pancreas. A mul

read more>>

Reporting in Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the bodyThe process calle

read more>>

A novel – and rapid – anti-cancer drug development strategy has resulted in a new drug that stops kidney and pancreatic tumors from growing in miceResearchers at the Moores Cancer Center at the University of California, San Diego, have found a drug that binds to a molecular "switch" fo

read more>>

Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, a study by researchers at UCLA's Jonsson High lev

read more>>

AMES, Iowa -- NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancerPancreatic cancer is highly lethal

read more>>

CRANBURY, NJ -- Cornerstone Pharmaceuticals, Inc. (http://www.cornerstonepharma.com), the private pharmaceutical company behind experimental cancer drug CPI-613 - with multiple ongoing phase I/II clinical trials - has announced it has added Pivotal Research Centers (www.pivotalresearch.com), &ldqu

read more>>

PHILADELPHIA -- Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft drinks, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association

read more>>

PHILADELPHIA -- The levels of an inflammatory chemokine were significantly elevated in patients with pancreatic cancer who were extremely obese, according to research conducted by scientists at the Jefferson Pancreatic, Biliary and Related Cancers CenterThey presented their data at the 5th Annual

read more>>

Researchers at the Moores Cancer Center at the University of California, San Diego, have found one reason that pancreatic cancer tumors are so difficult to treat with drugsThey have shown how a molecular switch steps up pancreatic cancer cell survival as well as resistance to a standard chemothera

read more>>